SMARCC1 and cyclic hematopoiesis: Recently, our group performed a trio‐based WES in 177 CH probands—the majority being sporadic—and identified four novel CH risk genes (TRIM71, SMARCC1, PTCH1, and SHH) that account for ~10% of studied cases (Furey et al., 2018).